VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 75 filers reported holding VAXCYTE INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $54,944,000 | -6.2% | 2,309,554 | 0.0% | 4.23% | -9.8% |
Q3 2021 | $58,593,000 | +12.7% | 2,309,554 | 0.0% | 4.69% | -2.2% |
Q2 2021 | $51,988,000 | +14.0% | 2,309,554 | 0.0% | 4.79% | +31.0% |
Q1 2021 | $45,614,000 | -25.7% | 2,309,554 | 0.0% | 3.66% | -22.6% |
Q4 2020 | $61,365,000 | -46.2% | 2,309,554 | 0.0% | 4.73% | -53.8% |
Q3 2020 | $114,046,000 | +56.2% | 2,309,554 | 0.0% | 10.24% | +59.7% |
Q2 2020 | $73,005,000 | – | 2,309,554 | – | 6.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 4,168,718 | $82,124,000 | 28.36% |
Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $37,277,000 | 21.71% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,405,421 | $27,757,000 | 8.90% |
FRAZIER MANAGEMENT LLC | 2,309,554 | $45,614,000 | 3.66% |
RA Capital Management | 3,865,808 | $76,350,000 | 1.15% |
TPG Group Holdings (SBS) Advisors, Inc. | 4,558,475 | $90,030,000 | 1.05% |
Soleus Capital Management, L.P. | 293,650 | $5,800,000 | 1.04% |
Opaleye Management Inc. | 357,800 | $7,067,000 | 1.04% |
SABBY MANAGEMENT, LLC | 178,992 | $3,535,000 | 0.69% |
Penn Mutual Asset Management, LLC | 22,227 | $439,000 | 0.50% |